Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report

Renal cell carcinoma is a malignant tumor that arises in the kidney parenchyma. For many years, sunitinib has represented the mainstay of medical treatment for metastatic renal cell carcinoma. Herein, we present the case of a 66-year-old woman with metastatic clear cell renal carcinoma undergoing tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Massucci, Maria, Mollica, Veronica, Rizzo, Alessandro, Ventrella, Laura, Maggio, Ilaria, Manuzzi, Lisa, Gatto, Lidia, Brandi, Giovanni, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826710/
https://www.ncbi.nlm.nih.gov/pubmed/33440621
http://dx.doi.org/10.3390/medicines8010005
_version_ 1783640585353035776
author Massucci, Maria
Mollica, Veronica
Rizzo, Alessandro
Ventrella, Laura
Maggio, Ilaria
Manuzzi, Lisa
Gatto, Lidia
Brandi, Giovanni
Massari, Francesco
author_facet Massucci, Maria
Mollica, Veronica
Rizzo, Alessandro
Ventrella, Laura
Maggio, Ilaria
Manuzzi, Lisa
Gatto, Lidia
Brandi, Giovanni
Massari, Francesco
author_sort Massucci, Maria
collection PubMed
description Renal cell carcinoma is a malignant tumor that arises in the kidney parenchyma. For many years, sunitinib has represented the mainstay of medical treatment for metastatic renal cell carcinoma. Herein, we present the case of a 66-year-old woman with metastatic clear cell renal carcinoma undergoing treatment with sunitinib for two years that developed encephalic leukocytoclastic vasculitis, probably due to a paraneoplastic syndrome.
format Online
Article
Text
id pubmed-7826710
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78267102021-01-25 Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report Massucci, Maria Mollica, Veronica Rizzo, Alessandro Ventrella, Laura Maggio, Ilaria Manuzzi, Lisa Gatto, Lidia Brandi, Giovanni Massari, Francesco Medicines (Basel) Case Report Renal cell carcinoma is a malignant tumor that arises in the kidney parenchyma. For many years, sunitinib has represented the mainstay of medical treatment for metastatic renal cell carcinoma. Herein, we present the case of a 66-year-old woman with metastatic clear cell renal carcinoma undergoing treatment with sunitinib for two years that developed encephalic leukocytoclastic vasculitis, probably due to a paraneoplastic syndrome. MDPI 2021-01-11 /pmc/articles/PMC7826710/ /pubmed/33440621 http://dx.doi.org/10.3390/medicines8010005 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Massucci, Maria
Mollica, Veronica
Rizzo, Alessandro
Ventrella, Laura
Maggio, Ilaria
Manuzzi, Lisa
Gatto, Lidia
Brandi, Giovanni
Massari, Francesco
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report
title Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report
title_full Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report
title_fullStr Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report
title_full_unstemmed Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report
title_short Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report
title_sort encephalic leukocytoclastic vasculitis during treatment with sunitinib for renal cell carcinoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826710/
https://www.ncbi.nlm.nih.gov/pubmed/33440621
http://dx.doi.org/10.3390/medicines8010005
work_keys_str_mv AT massuccimaria encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport
AT mollicaveronica encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport
AT rizzoalessandro encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport
AT ventrellalaura encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport
AT maggioilaria encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport
AT manuzzilisa encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport
AT gattolidia encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport
AT brandigiovanni encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport
AT massarifrancesco encephalicleukocytoclasticvasculitisduringtreatmentwithsunitinibforrenalcellcarcinomaacasereport

Ejemplares similares